Neurologic Oncology News & Articles

1 Minimal residual disease is a prognostic marker for neuroblastoma with bone marrow infiltration American Journal of Clinical Oncology, May 23, 2012

2 Nestin Expression Identifies Ependymoma Patients with Poor Outcome Brain Pathology, May 23, 2012

3 Therapy-resistant tumor microvascular endothelial cells contribute to treatment failure in glioblastoma multiforme Oncogene, May 23, 2012

4 SSBP2 variants are associated with survival in glioblastoma patients Clinical Cancer Research, May 22, 2012

5 Pseudoprogression in Patients With Glioblastoma Multiforme After Concurrent Radiotherapy and Temozolomide American Journal of Clinical Oncology, May 22, 2012    Clinical Article

6 Monitoring and evaluation tools for irinotecan and bevacizumab in glioblastoma Bulletin du Cancer, May 22, 2012    Clinical Article

7 Isolated central nervous system relapses in primary mediastinal large B-cell lymphoma after CHOP-like chemotherapy with or without Rituximab Hematological Oncology, May 22, 2012    Clinical Article

8 Hypofractionated frameless stereotactic intensity-modulated radiotherapy with whole brain radiotherapy for the treatment of 1-3 brain metastases Neurological Sciences, May 22, 2012

9 Extracranial metastasizing solitary fibrous tumors (SFT) of meninges: Histopathological features of a case with long-term follow-up Neuropathology, May 21, 2012

10 Size of Tooth Crowns and Position of Teeth Concerning the Extension of Facial Plexiform Neurofibroma in Patients with Neurofibromatosis Type 1 Anticancer Research, May 17, 2012

11 Superior recovery profiles of propofol-based regimen as compared to isoflurane-based regimen in patients undergoing craniotomy for primary brain tumor excision: a retrospective study Journal of Anesthesia, May 17, 2012    Clinical Article

12 miR-34a functions as a tumor suppressor modulating EGFR in glioblastoma multiforme Oncogene, May 16, 2012

13 Stereotactic iodine-125 brachytherapy for treatment of inoperable focal brainstem gliomas of WHO grades I and II: feasibility and long-term outcome Journal of Neuro-Oncology, May 16, 2012

14 Primary central nervous system plasmablastic lymphoma presenting in human immunodeficiency virus-negative but Epstein-Barr virus-positive patient: A case report Diagnostic Pathology, May 16, 2012

15 Comorbidity assessment and adjuvant radiochemotherapy in elderly affected by glioblastoma Medical Oncology, May 16, 2012    Clinical Article

16 Stratification according to HGG-IMMUNO RPA model predicts outcome in a large group of patients with relapsed malignant glioma treated by adjuvant postoperative dendritic cell vaccination Cancer Immunology, Immunotherapy, May 15, 2012

17 Polymorphisms of TREH, IL4R and CCDC26 genes associated with risk of glioma Cancer Epidemiology, May 15, 2012

18 Frequent BRAF Gain in Low-grade Diffuse Gliomas with 1p/19q Loss Brain Pathology, May 15, 2012

19 Rituximab significantly improves complete response rate in patients with primary CNS lymphoma Journal of Neuro-Oncology, May 15, 2012    Clinical Article

20 Development of robust discriminant equations for assessing subtypes of glioblastoma biopsies British Journal of Cancer, May 14, 2012

Stereotactic ablative radiotherapy for stage I NSCLC: Recent advances and controversies Journal of Thoracic Disease, 08/05/2011

1 Coffee, tea, soda, and caffeine intake in relation to risk of adult glioma in the NIH-AARP Diet and Health Study Cancer Causes and Control, April 4, 2012

2 New prognostic factors and calculators for outcome prediction in patients with recurrent glioblastoma: A pooled analysis of EORTC Brain Tumour Group phase I and II clinical trials European Journal of Cancer, April 6, 2012

3 Results of phase I study of a multi-modality treatment for newly diagnosed glioblastoma multiforme using local implantation of concurrent BCNU wafers and permanent I-125 seeds followed by fractionated radiation and temozolomide chemotherapy Journal of Neuro-Oncology, April 10, 2012

4 Effect of chemotherapy on survival after whole brain radiation therapy for brain metastases: a single-center retrospective analysis Journal of Cancer Research & Clinical Oncology, March 27, 2012

5 Adult glioblastoma multiforme survival in the temozolomide era: A population-based analysis of Surveillance, Epidemiology, and End Results registries Cancer, April 17, 2012

6 Phase II Study of Weekly Vinblastine in Recurrent or Refractory Pediatric Low-Grade Glioma Journal of Clinical Oncology, March 8, 2012

7 The clinical features and surgical outcomes of pediatric patients with primary spinal cord tumor Child's Nervous System, April 2, 2012

8 Dental x-rays and risk of meningioma Cancer, April 12, 2012

9 Phase I Study of Vincristine, Irinotecan, and 131I-Metaiodobenzylguanidine (131I-MIBG) for Patients with Relapsed or Refractory Neuroblastoma Clinical Cancer Research, April 5, 2012

10 Clinical significance of KISS1 protein expression for brain invasion and metastasis Cancer, April 17, 2012

11 Extended adjuvant temozolomide for treatment of newly diagnosed glioblastoma multiforme Journal of Neuro-Oncology, March 5, 2012

12 Evidence-Based Treatment of Primary and Recurrent Brain Metastasis Journal of Neurological Sciences (Turkish), April 11, 2012    Free full text    Evidence Based Medicine

13 Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial The Lancet Oncology - Online First, March 28, 2012

14 An evaluation of the safety and feasibility of convection-enhanced delivery of carboplatin into the white matter as a potential treatment for high-grade glioma Journal of Neuro-Oncology, April 10, 2012

15 HMG CoA reductase inhibitors, NSAIDs and risk of glioma International Journal of Cancer, March 20, 2012

16 Clinical Implications of Molecular Neuropathology and Biomarkers for Malignant Glioma Current Neurology and Neuroscience Reports, April 12, 2012

17 Surgical Mortality and Selected Complications in 273 Consecutive Craniotomies for Intracranial Tumors in Pediatric Patients Neurosurgery, April 6, 2012

18 Phase 2 trial of irinotecan and thalidomide in adults with recurrent anaplastic glioma Cancer, April 17, 2012

19 Narciclasine as well as other Amaryllidaceae Isocarbostyrils are Promising GTP-ase Targeting Agents against Brain Cancers Medicinal Research Reviews, April 16, 2012

20 Postoperative radiation therapy for low-grade glioma Cancer, April 24, 2012